Frg1-KO Mouse
一般名
Frg1-KO
製品ID
S-KO-02117
背景情報
C57BL/6JCya
系統ID
KOCMP-14300-Frg1-B6J-VB
状況
このマウス系統を論文で使用する場合は、「Frg1-KO Mouse(カタログ番号S-KO-02117)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Frg1-KO
系統ID
KOCMP-14300-Frg1-B6J-VB
遺伝子名
製品ID
S-KO-02117
遺伝子別名
--
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000033999
NCBIトランスクリプトID
NM_013522
ターゲット領域
Exon 3~4
有効領域の大きさ
~1.9 kb
遺伝子研究の概要
FRG1, short for FSHD region gene 1, is the primary candidate gene for Fascioscapulohumeral Muscular Dystrophy (FSHD). It has been implicated in multiple physiological processes. Mechanistically, it may play a role in RNA biogenesis, influencing pathways like mRNA surveillance, RNA transport, and spliceosome machinery [1]. It is also associated with processes such as muscle development, vasculogenesis, angiogenesis, and tumorigenesis [1,2,3,4,5,6,7,8]. Genetic models, like those in Xenopus laevis and mouse myoblasts, have been valuable in studying its functions [7,9].
In terms of specific findings, in Xenopus laevis, frg1 is expressed in and essential for tadpole musculature development. Disrupting its expression led to myotome organization and growth defects, while overexpression caused abnormal muscle formation, suggesting its crucial role in proper muscle development [7]. In mouse myoblasts overexpressing FRG1, decreased proliferation was observed, which may contribute to the pathology of FSHD [9]. In cancer studies, reduced FRG1 expression promoted angiogenesis via the FGF2-mediated ERK/AKT pathway in breast cancer [2], and in prostate cancer, it affected cell migration and invasion, likely through p38 MAPK activation [4]. FRG1 also seems to play a role in DNA repair in breast cancer, with low expression associated with reduced DNA repair capabilities and a higher frequency of TP53 mutation [3].
In conclusion, FRG1 is vital for muscle development and has significant implications in angiogenesis, tumorigenesis, and DNA repair. Studies using genetic models, especially in muscle-related and cancer-related disease areas, have revealed its multifaceted functions. Understanding FRG1 can potentially provide insights into the pathophysiology of FSHD and cancer, offering new directions for therapeutic strategies.
References:
1. Palo, Ananya, Patel, Saket Awadhesbhai, Sahoo, Bibekananda, Chowdary, Tirumala Kumar, Dixit, Manjusha. 2022. FRG1 is a direct transcriptional regulator of nonsense-mediated mRNA decay genes. In Genomics, 115, 110539. doi:10.1016/j.ygeno.2022.110539. https://pubmed.ncbi.nlm.nih.gov/36521634/
2. Mukherjee, Bratati, Brahma, Pratush, Mohapatra, Talina, Chawla, Saurabh, Dixit, Manjusha. 2023. Reduced FRG1 expression promotes angiogenesis via activation of the FGF2-mediated ERK/AKT pathway. In FEBS open bio, 13, 804-817. doi:10.1002/2211-5463.13582. https://pubmed.ncbi.nlm.nih.gov/36815234/
3. Shubhanjali, Shubhanjali, Mohapatra, Talina, Khan, Rehan, Dixit, Manjusha. 2024. Unveiling FRG1's DNA repair role in breast cancer. In Scientific reports, 14, 19371. doi:10.1038/s41598-024-70368-9. https://pubmed.ncbi.nlm.nih.gov/39169067/
4. Tiwari, Ankit, Mukherjee, Bratati, Hassan, Md Khurshidul, Jaiswal, Archita Mohanty, Dixit, Manjusha. 2019. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion. In BMC cancer, 19, 346. doi:10.1186/s12885-019-5509-4. https://pubmed.ncbi.nlm.nih.gov/30975102/
5. Mukherjee, Bratati, Tiwari, Ankit, Palo, Ananya, Samantara, Subrat, Dixit, Manjusha. 2022. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF. In Cell death discovery, 8, 442. doi:10.1038/s41420-022-01240-w. https://pubmed.ncbi.nlm.nih.gov/36329016/
6. DeSimone, Alec M, Pakula, Anna, Lek, Angela, Emerson, Charles P. 2017. Facioscapulohumeral Muscular Dystrophy. In Comprehensive Physiology, 7, 1229-1279. doi:10.1002/cphy.c160039. https://pubmed.ncbi.nlm.nih.gov/28915324/
7. Hanel, Meredith L, Wuebbles, Ryan D, Jones, Peter L. . Muscular dystrophy candidate gene FRG1 is critical for muscle development. In Developmental dynamics : an official publication of the American Association of Anatomists, 238, 1502-12. doi:10.1002/dvdy.21830. https://pubmed.ncbi.nlm.nih.gov/19097195/
8. Hansda, Arman Kunwar, Tiwari, Ankit, Dixit, Manjusha. . Current status and future prospect of FSHD region gene 1. In Journal of biosciences, 42, 345-353. doi:. https://pubmed.ncbi.nlm.nih.gov/28569257/
9. Chen, Steven C, Frett, Ellie, Marx, Joseph, Kyba, Michael, Kennedy, Brian K. 2011. Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1. In PloS one, 6, e19780. doi:10.1371/journal.pone.0019780. https://pubmed.ncbi.nlm.nih.gov/21603621/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
